Equities
Consumer ServicesFood & Drug Retailers
  • Price (USD)73.59
  • Today's Change-0.67 / -0.90%
  • Shares traded3.90m
  • 1 Year change0.30%
  • Beta0.8821
Data delayed at least 15 minutes, as of Dec 13 2019 23:30 GMT.
More ▼

Profile data is unavailable for this security.

About the company

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

  • Revenue in USD (TTM)244.80bn
  • Net income in USD4.36bn
  • Incorporated1996
  • Employees295.00k
  • Location
    CVS Health Corp1 Cvs DrWOONSOCKET 02895-6146United StatesUSA
  • Phone+1 (401) 765-1500
  • Fax+1 (302) 655-5049
  • Websitehttps://www.cvshealth.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CVS:NYQ since
announced
Transaction
value
Illinicare Health Plan IncAnnounced02 Dec 201902 Dec 2019Announced-2.23%--
Data delayed at least 15 minutes, as of Dec 13 2019 23:30 GMT.

Institutional shareholders

29.56%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 2019101.62m7.81%
SSgA Funds Management, Inc.as of 30 Sep 201960.59m4.66%
BlackRock Fund Advisorsas of 30 Sep 201958.83m4.52%
Wellington Management Co. LLPas of 30 Sep 201940.50m3.11%
Capital Research & Management Co. (International Investors)as of 30 Sep 201924.30m1.87%
Fidelity Management & Research Co.as of 30 Sep 201922.09m1.70%
Dodge & Coxas of 30 Sep 201920.85m1.60%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 201919.19m1.48%
Geode Capital Management LLCas of 30 Sep 201918.33m1.41%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 201918.22m1.40%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.